Bayer AG (BAYN.DE) is the underlying asset for a new equity-linked bond offering a 10.5% coupon, a move that highlights the strong speculative interest in the German pharmaceutical and agrochemical giant.
The instrument, reported by German business magazine Wiwo, targets investors seeking high yields while betting on the continued upward trajectory of Bayer's volatile stock.
The issuance comes as Bayer shares have surged in European trading, recently climbing significantly to lead the DAX index.
The rally has been fueled by a combination of positive analyst commentary, including upgrades from Deutsche Bank, and growing market speculation regarding the company's strategic direction.
The availability of such a high-yield derivative suggests that market makers and institutional investors view the current price momentum as sustainable enough to support leveraged bets.
Bayer's stock has been a focal point for traders due to its high volatility and general upward trend, making it an ideal candidate for structured products.